Please ensure Javascript is enabled for purposes of website accessibility

Search

15,130 Results for "👉 acc6.top 👈🏻 buy a subscription Telegram account"
15,130 Results for "👉 acc6.top 👈🏻 buy a subscription Telegram account".
  • Last Thursday, in a financial story that you may have missed, Nasdaq OMX Group announced that it had created a new index. It’s called the Nasdaq OMX Government Relief Index and it is now trading under the symbol QGRI. The components of the index will be the companies that receive $1 billion or more under the Troubled Asset Relief Program (TARP) or any other government handout program. Creating and updating indexes like The Bailout Index (my term) is one way financial services companies make a living. But I think I’ll give The Bailout Index a pass
  • With the MSCI Emerging Markets Index headed steeply down since June 13, we have been moving quickly to cut our exposure and kick losers out of our portfolio. It’s not pleasant, but it’s the only way to stay profitable in a volatile sector like emerging market stocks. Today’s bounce in the markets was a welcome relief from the selling pressure, but we will discount the good news until the Cabot Emerging Markets Timer gives us the all-clear.
  • It’s been a positive earnings season so far. But the market keeps rolling along just as it had before earnings.

    It’s the same story as it was a month ago, technology is struggling while cyclical sectors are soaring. The S&P 500 has managed an anemic YTD return of 1.27% while energy, consumer, material, and industrial stocks are lighting it up with YTD returns of 19.32%, 14%, 12.45%, and 11.61%, respectively, for the sectors. The bull market continues to broaden out and leave technology behind.
  • From the start of October through the tail end of November, growth stocks (and, more generally, high relative strength stocks) were the dog’s dinner, flailing around even as the major indexes advanced. Now, though, with many stocks having etched two-month launching pads, the tone has improved—money is slowly (emphasis on slowly) coming out of defensive names and into faster movers. A bit more improvement and we’ll shift our Market Monitor into bullish territory, but for now, we’ll stick with our general “lean bullish” stance.

    Another good sign is that, in this week’s list, we see many stocks that have shown recent power and are trading relatively tightly, a good sign of accumulation. Our favorite of the week is Harman International (HAR), a well-situated audio firm with very solid sales and earnings growth. The stock looks like it’s at a good entry around here.
    Stock NamePriceBuy RangeLoss Limit
    Perrigo (PRGO) 0.00151-154140-142
    Las Vegas Sands Corp. (LVS) 0.0074-7768-69
    Illumina Inc. (ILMN) 289.7497-10190-91
    Harman International Industries, Inc. (HAR) 0.0078-8070-71
    Financial Engines (FNGN) 0.0065-68.559-60
    Deckers Outdoor Corp. (DECK) 141.6883-8570-71
    Conn’s Inc. (CONN) 0.0069-7363-64
    Baidu (BIDU) 0.00165-170140-145
    AOL, Inc. (AOL) 0.0042.5-4539-40
    Ambarella (AMBA) 52.7923-24.520.5-21.5

  • Cloud computing is what’s holding both the world and the stock market together through these trying times. Here are the best cloud computing stocks.
  • WHAT TO DO NOW: Remain defensive. The market has gotten off its duff somewhat this week, but as seen the past couple of weeks, there’s still plenty of selling and news-driven action out there. We do think it’s possible a repair process has begun, but right now, the trends of the major indexes and most stocks are pointed down, so we continue to advise a defensive stance. We’ll again stand pat tonight with our four small-ish positions and our big cash position, though we’ll be on the horn if we have any changes (including possibly re-jiggering the portfolio a bit) in the days ahead.
  • The market remains super strong, and we’re pleased to see many growth stocks that rested during December break out to new highs so far this year. Shorter-term, the lack of good entry points among stocks we’re watching is a reason we’re still holding a chunk of cash on the sideline. But we remain very bullish longer-term and think pullbacks and/or shakeouts will provide some solid entry points.

    Tonight, we’re standing pat once again with our collection of stocks, most of which act great. In the issue, we do write about one big-cap name that we think has regained its status as a liquid leader (Alibaba), and it’s probably the top stock on our watch list today. Elsewhere we do highlight some other ideas, and as always, share our latest thoughts on all the stocks we own.

  • One of our big initiatives at Cabot this year was to start incorporating video into our content. Most of our video push has been in the form of Webinars, or online seminars, hosted by our editors.
  • Many companies became extinct in the 1930s, but the companies that survived helped to build the U.S. into the greatest industrial nation to date. It is surprising how many of our current U.S. companies were founded more than 150 years ago.
  • The market forces do have a profound effect, as illustrated recently by the bourbon and oil markets.
  • I’ll write about 10 stocks that have been featured in both Top Ten Trader and Benjamin Graham Value Investor.
  • Led by mega-cap tech stocks, the indexes tacked on modest gains last week. The S&P 500 rose 1%, the Dow added 0.84%, and the Nasdaq gained 0.7%.
  • Led by mega-cap tech stocks, the indexes tacked on modest gains last week. The S&P 500 rose 1%, the Dow added 0.84%, and the Nasdaq gained 0.7%.
  • WHAT TO DO NOW: Remain defensive. Early January is often marked by crosscurrents, and this year is no different, with a few intriguing rays of light popping up—but the market’s trends are pointed down and there remain far more sinkholes than shooting stars among individual stocks. In the Model Portfolio, we’ve shielded most of our money from harm’s way in recent weeks, but a couple of our names have been getting hit with growth stocks of late. Tonight, we’re forced to sell our half position in Enphase Energy (ENPH), bringing our cash position up to 80%. Details below.
  • The historic move in the bond market continued to weigh on stocks last week as the S&P 500 lost 2.4%, the Dow fell 1.6% and the Nasdaq declined by 3.1%.
  • The historic move in the bond market continued to weigh on stocks last week as the S&P 500 lost 2.4%, the Dow fell 1.6% and the Nasdaq declined by 3.1%.
  • Market Gauge is 5Current Market Outlook


    Stocks had another great week, with the major indexes posting solid gains, many potential leaders approaching new highs and market breadth being so positive that it flashed a rare “blastoff” green light. Thus, our confidence is growing that the worst has passed—though that doesn’t mean the market doesn’t face many weeks of bottom building, either. Long story short, the evidence has improved, though it’s worth remembering that the intermediate-term trend of the indexes and most stocks remains down. All in all, we’re OK extending your line a bit, doing some new buying in high-potential stocks, but we’re also still keeping a good chunk of cash on the sideline and waiting for more strength to develop (maybe after a retrenchment) before turning bullish. Our Market Monitor moves to a level 5 this week.

    As for the list, today is another batch of good-looking stocks from a variety of sectors, albeit with a heavier emphasis on medical. Our Top Pick is old favorite Dexcom (DXCM)—start small and build if the recent strength continues.
    Stock NamePriceBuy RangeLoss Limit
    Array Biopharma (ARRY) 46.3516.5-17.515-15.5
    Cree, Inc. (CREE) 67.9644.5-46.541-42
    Dexcom (DXCM) 421.36137-144122-126
    Everbridge (EVBG) 107.9053-5649-50.5
    Five Below (FIVE) 134.58112-117100-103
    Ionis Pharmaceuticals (IONS) 73.3455.5-57.551-52
    Keysight Technologies, Inc. (KEYS) 97.2064-66.558.5-60.5
    LGI Homes (LGIH) 86.0454-5749-51
    Tandem Diabetes (TNDM) 74.7739.5-42.533.5-35.5
    Vertex Pharmaceuticals (VRTX) 230.36180-187165-169

  • They are two of the most recognizable names out there, and good stocks, but which is the better buy? Let’s break down Apple vs. Amazon stock.
  • Cannabis legalization is spreading but cannabis stocks are trading near all-time lows, which leaves these four industry leaders poised for a rebound.